186 related articles for article (PubMed ID: 31184221)
21. LncRNA LINC00152 Increases the Aggressiveness of Human Retinoblastoma and Enhances Carboplatin and Adriamycin Resistance by Regulating MiR-613/Yes-Associated Protein 1 (YAP1) Axis.
Wang Y; Xin D; Zhou L
Med Sci Monit; 2020 Jun; 26():e920886. PubMed ID: 32541644
[TBL] [Abstract][Full Text] [Related]
22. Dysregulation of LncRNA ANRIL mediated by miR-411-3p inhibits the malignant proliferation and tumor stem cell like property of multiple myeloma via hypoxia-inducible factor 1α.
Wang M; Zhao HY; Zhang JL; Wan DM; Li YM; Jiang ZX
Exp Cell Res; 2020 Nov; 396(1):112280. PubMed ID: 32961145
[TBL] [Abstract][Full Text] [Related]
23. Long non-coding RNA LPP-AS2 promotes glioma tumorigenesis via miR-7-5p/EGFR/PI3K/AKT/c-MYC feedback loop.
Zhang X; Niu W; Mu M; Hu S; Niu C
J Exp Clin Cancer Res; 2020 Sep; 39(1):196. PubMed ID: 32962742
[TBL] [Abstract][Full Text] [Related]
24. Long non-coding RNA LINC00152/miR-613/CD164 axis regulates cell proliferation, apoptosis, migration and invasion in glioma via PI3K/AKT pathway.
Zhang L; Wang Y; Su H
Neoplasma; 2020 Jul; 67(4):762-772. PubMed ID: 32726126
[TBL] [Abstract][Full Text] [Related]
25. Potential Role of Long Non-Coding RNA ANRIL in Pediatric Medulloblastoma Through Promotion on Proliferation and Migration by Targeting miR-323.
Zhang H; Wang X; Chen X
J Cell Biochem; 2017 Dec; 118(12):4735-4744. PubMed ID: 28513871
[TBL] [Abstract][Full Text] [Related]
26. Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer.
Huang Y; Ni R; Wang J; Liu Y
Biomed Pharmacother; 2019 Jan; 109():1851-1859. PubMed ID: 30551440
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of LncRNA ANRIL Potential in Hepatic Cancer Progression.
Ji Y; Sun H; Liang H; Wang Y; Lu M; Guo Z; Lv Z; Ren W
J Environ Pathol Toxicol Oncol; 2019; 38(2):119-131. PubMed ID: 31679275
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of lncRNA ANRIL aggravated hydrogen peroxide-disposed injury in PC-12 cells via inhibiting miR-499a/PDCD4 axis-mediated PI3K/Akt/mTOR/p70S6K pathway.
Guo Z; Li L; Gao Y; Zhang X; Cheng M
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2624-2633. PubMed ID: 31220946
[TBL] [Abstract][Full Text] [Related]
29. Knockdown of lncRNA PVT1 inhibits retinoblastoma progression by sponging miR-488-3p.
Wu XZ; Cui HP; Lv HJ; Feng L
Biomed Pharmacother; 2019 Apr; 112():108627. PubMed ID: 30797143
[TBL] [Abstract][Full Text] [Related]
30. CircCUL2 suppresses retinoblastoma cells by regulating miR-214-5p/E2F2 Axis.
Zhang H; Qiu X; Song Z; Lan L; Ren X; Ye B
Anticancer Drugs; 2022 Jan; 33(1):e218-e227. PubMed ID: 34387590
[TBL] [Abstract][Full Text] [Related]
31. Long Noncoding RNA LINC00202 Promotes Tumor Progression by Sponging miR-3619-5p in Retinoblastoma.
Yan G; Su Y; Ma Z; Yu L; Chen N
Cell Struct Funct; 2019; 44(1):51-60. PubMed ID: 30905893
[TBL] [Abstract][Full Text] [Related]
32. LncRNA ANRIL promotes angiogenesis and thrombosis by modulating microRNA-99a and microRNA-449a in the autophagy pathway.
Zeng R; Song XJ; Liu CW; Ye W
Am J Transl Res; 2019; 11(12):7441-7448. PubMed ID: 31934291
[TBL] [Abstract][Full Text] [Related]
33. Silencing UNC5B antisense lncRNA 1 represses growth and metastasis of human Colon cancer cells via raising miR-622.
Zhang Y; Li Z; Lan Z
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):60-67. PubMed ID: 31852293
[No Abstract] [Full Text] [Related]
34. RETRACTED: ANRIL acts as onco-lncRNA by regulation of microRNA-24/c-Myc, MEK/ERK and Wnt/β-catenin pathway in retinoblastoma.
Yu F; Pang G; Zhao G
Int J Biol Macromol; 2019 May; 128():583-592. PubMed ID: 30703428
[TBL] [Abstract][Full Text] [Related]
35. c-Myc-activated long non-coding RNA H19 downregulates miR-107 and promotes cell cycle progression of non-small cell lung cancer.
Cui J; Mo J; Luo M; Yu Q; Zhou S; Li T; Zhang Y; Luo W
Int J Clin Exp Pathol; 2015; 8(10):12400-9. PubMed ID: 26722426
[TBL] [Abstract][Full Text] [Related]
36. LncRNA ANRIL protects against oxygen and glucose deprivation (OGD)-induced injury in PC-12 cells: potential role in ischaemic stroke.
Liu B; Cao W; Xue J
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1384-1395. PubMed ID: 31174432
[TBL] [Abstract][Full Text] [Related]
37. Long noncoding RNA ANRIL indicates a poor prognosis of gastric cancer and promotes tumor growth by epigenetically silencing of miR-99a/miR-449a.
Zhang EB; Kong R; Yin DD; You LH; Sun M; Han L; Xu TP; Xia R; Yang JS; De W; Chen Jf
Oncotarget; 2014 Apr; 5(8):2276-92. PubMed ID: 24810364
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-129-5p suppresses proliferation, migration and invasion of retinoblastoma cells through PI3K/AKT signaling pathway by targeting PAX6.
Liu Y; Liang G; Wang H; Liu Z
Pathol Res Pract; 2019 Dec; 215(12):152641. PubMed ID: 31727502
[TBL] [Abstract][Full Text] [Related]
39. Knockdown of ANRIL aggravates H
Li R; Yin F; Guo YY; Zhao KC; Ruan Q; Qi YM
Biomed Pharmacother; 2017 Aug; 92():952-961. PubMed ID: 28609843
[TBL] [Abstract][Full Text] [Related]
40. Long non-coding RNA ANRIL down-regulates microRNA-7 to protect human trabecular meshwork cells in an experimental model for glaucoma.
Zhao J; Sun H; Zhang JM; Wang M; Du XJ; Zhang JL
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3173-3182. PubMed ID: 31081068
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
